Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation.
The incidence of graft-versus-host disease (GVHD) after cord blood (CB) transplantation (CBT) is lower than expected given the marked degree of human leukocyte antigen (HLA)-mismatch of CB grafts. While the exact mechanism that underlies this biology remains unclear, it is hypothesized to be due to the low number of mostly immature T-cells infused as part of the graft1,2, and increased tolerance of CB-derived lymphocytes induced by the state of pregnancy. Nevertheless, acute GVHD (aGVHD) is a significant complication of CBT. In contrast, the incidence of chronic GVHD (cGVHD) following CBT is lower than what is observed following matched related or unrelated donor HSC transplantation (HSCT)3-6. This review outlines the guidelines for the prevention and management of acute and chronic GVHD following CBT.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Unrelated Donors
- Immunology
- Humans
- Hematopoietic Stem Cell Transplantation
- HLA Antigens
- Graft vs Host Disease
- Cord Blood Stem Cell Transplantation
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Unrelated Donors
- Immunology
- Humans
- Hematopoietic Stem Cell Transplantation
- HLA Antigens
- Graft vs Host Disease
- Cord Blood Stem Cell Transplantation
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences